top of page

SCIENTIFIC PROGRAMME

green.png

TUESDAY

TUESDAY 7th JULY

08:15 - 09:00

Registration opens

09:00 - 10:30

RAPID-FIRE SESSION

Chairs: Prof Susan Mollan, Birmingham, UK and Kingston, Canada & Prof Rachel Pilling, Bradford, UK

​

Randomised Controlled Trial of Topical Combination Therapy Chlorhexidine 0.2% and Natamycin 5% Versus Topical Natamycin 5% Alone for Fungal Keratitis in East Africa

Jeremy Hoffman, London, UK

​

Improving the Molecular Diagnostic Rate for Developmental Glaucoma in the 100,000 Genomes Project

Nicky Cronbach, London, UK

​

Automated AI-Based Coregistration Platform for Microperimetry and Optical Coherence Tomography Enables Structure-Function Analysis in Retinal Disease

Vasil Kostin, Oxford, UK

​

Four-Year Outcomes of Faricimab in nAMD: Safety and Efficacy Results From the AVONELLE-X Long-Term Extension Trial

James Talks, Newcastle, UK

​

Two-Year Effectiveness, Durability and Safety of Faricimab in Eyes With DMO: Results From the
UK FARWIDE-DMO Study

Christine Kiire, Oxford, UK

​

Metagenomics for Ocular Inflammation - Initial Insights and Results from a Single-Site UK Study

Daniyal Ansari, Maidstone, UK

​

Diabetic Retinopathy Screening Outcomes After age 80

Arya Ghatge, Gloucester, UK

​

Patient Reported Outcome Measures 1 Year after Uveal Melanoma Treatment

Catharine Kwok, Watford, UK

​

Calcitonin Gene-related Peptide Induces Headache Attacks in People With Idiopathic Intracranial Hypertension

Andreas Yiangou, Birmingham, UK

​

Nurse-led Optos Screening for Retinopathy of Prematurity (ROP)

Venughanan Manikavasagar, Derby, UK

​

Neurofilament Light Chain as a Biomarker of Treatment Response in Idiopathic Intracranial Hypertension: a Longitudinal Study From the Idiopathic Intracranial Hypertension Weight Trial

Michael Lowe, Birmingham, UK

​

Primary Results of the Phase 3 SatraGO-1 and SatraGO-2 Trials: Efficacy and Safety of Satralizumab in Thyroid Eye Disease

Daniel G Ezra, London, UK

​

Microneedle delivery of stem cell-derived retinal pigment epithelial cells

Jared Ching, Yokohama, Japan. Oxford, UK. Singapore

​

Efficacy of Intra-Retinal Arterial Cannulation for Central Retinal Artery Occlusion with Visible Platelet-Fibrin Emboli

Shin Tanaka, Yokohama, Japan. Oxford, UK

10:30 - 11:15

Refreshments, Exhibition, Posters

11:15 - 12:30

DOYNE LECTURE: Title to be revealed

​

Lecturer: Prof Chris Hammond, London, UK

 

Introduction and Doyne Medal presentation: Mr Manoj V. Parulekar, Oxford & Birmingham, UK

12:30 - 14:00

Lunch, Exhibition, Posters

14:00 - 15:30

Letters on a chart mean nothing

Chairs: Mr S. James Talks, Newcastle, UK & Ms Marie Hickey Dwyer, Limerick, Ireland

 

Vision and choice of career 

Patrick Watts, Cardiff, UK


Visual field loss in glaucoma

David Crabb, London, UK


Visual loss in macular disease

Susan Downes, Oxford, UK


Visual impact of nystagmus

Jay Self, Southampton, UK
 

Vision and driving 

TBC
 

Discussion

Panel Questions  

15:30 - 16:00

Refreshment, Exhibition, Posters

16:00 - 17:00

Focus on surgical techniques

Chairs: Ms Roxane Hillier, Newcastle, UK & Prof Sir Peng T. Khaw, London, UK

​

New strabismus techniques

TBC, Cheltenham, UK


IOLs in the absence of capsular support

TBC, Newcastle, UK


Lid injury repair

TBC, Cambridge, UK


Submacular surgery

Theo Potamitis, Limassol, Cyprus


Optic nerve decompression

Sachin Salvi, Sheffield, UK​

19:00

OOC GALA DINNER

Rhodes House Hall. Drinks from 19:00. Sit down to dinner @ 20:00

THE OXFORD OPHTHALMOLOGICAL CONGRESS. Charity number: 1181776

OOC Secretariat: Louise Richards, louise@healthology.eu, +44(0)7950 273790

 

Privacy policy

Refunds and cancellation policy

THE OXFORD OPHTHALMOLOGICAL CONGRESS. Founded by Robert W Doyne in 1909

2025 - 2026

Master: Mr Manoj Parulekar

Secretary: Prof Mandeep Sagoo 

Treasurer: Miss Samantha De Silva

Editor: Prof Susan Mollan 

Past Master: Mr James Talks

Deputy Master: Prof Bernard Chang

bottom of page